Children’s debit card provider Greenlight is valued at $1.2bn after raising $215m in funding from a host of investors, though none of its corporate backers participated this time.

Cancer drug developer Silverback has secured $211m to date from investors including BMS, Celgene and Alexandria Real Estate Equities.

Former B Capital Group partners have formed a $100m venture fund that will principally target Southeast Asia-based technology startups.

A month after receiving an initial $200m tranche from D1 Capital Partners, Alphabet and Roc Nation-backed Robinhood has increased its series G round $660m.

CapitalG has led a $250m series D round for Next Insurance, while Munich Re also returned for the deal that increased the workplace insurance provider’s total funding to $631m.

Foot Locker-backed sneaker marketplace Goat Group has completed a $100m round from D1 Capital Partners, bringing its overall financing to almost $300m in five years.

Avery Dennison and Valo Ventures both invested to lift recycling service provider RoadRunner's series C total to $38.9m.

The Manulife Financial, AllianceBernstein and Transamerica-backed financial planning service pushed its lifetime funding to $85m with a round featuring FP Credit, Oak HC/FT and IA Capital Group.

UCSF spinout Siolta Therapeutics picked up SymBiosis and Kirin Holdings in a round set to fund efficacy trials of its potential asthma treatment.

Siolta Therapeutics picked up SymBiosis and Kirin Holdings in a round set to fund efficacy trials of its potential asthma treatment.